It blocks tumor cell proliferation and tumor angiogenesis, and increases the rate of apoptosis in a wide range of tumor models by targeting the Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (RAF/MEK/ERK) and VEGF signaling pathways [6]. Here, MAPK1 is linked to neoplasm.